ストックスクリーナーアプリを入手
27.50
1.89%
0.51
前日終値:
$26.99
開ける：
$27.4999
24時間の取引高:
1,202
Relative Volume:
0.23
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+10.66%
1か月 パフォーマンス:
+8.27%
6か月 パフォーマンス:
+231.33%
1年 パフォーマンス:
+113.01%
1日の値動き範囲:
$27.46
$27.50
1週間の範囲:
$25.56
$27.50
52週間の値動き範囲:
$5.45
$29.55
Newamsterdam Pharma Company N V Stock (NAMSW) Company Profile
名前
Newamsterdam Pharma Company N V
セクター
電話
31 35 206 2971
住所
Gooimeer 2-35, Naarden
NAMSW を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NAMSW
Newamsterdam Pharma Company N V
|
27.50 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.20 | 103.89B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.74 | 69.11B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.70 | 58.49B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
869.83 | 52.62B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
191.92 | 40.46B | 447.02M | -1.18B | -906.14M | -6.1812 |
Newamsterdam Pharma Company N V (NAMSW) 最新ニュース
How NewAmsterdam Pharma Company N.V. (KH6) stock compares with tech leadersTrade Exit Summary & Weekly High Potential Stock Alerts - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock recover faster than marketEarnings Performance Report & Risk Managed Trade Strategies - newser.com
Risk adjusted return profile for NewAmsterdam Pharma Company N.V. Equity Warrant analyzedMarket Risk Report & Real-Time Volume Trigger Notifications - newser.com
Can NewAmsterdam Pharma Company N.V. (KH6) stock surprise markets with earningsJuly 2025 Decliners & Consistent Return Strategy Ideas - newser.com
How NewAmsterdam Pharma Company N.V. stock performs in high volatility marketsJuly 2025 Closing Moves & Safe Entry Point Identification - newser.com
Will earnings trigger a reversal in NewAmsterdam Pharma Company N.V. Equity WarrantProduct Launch & Advanced Technical Signal Analysis - newser.com
Visual analytics tools that track NewAmsterdam Pharma Company N.V. Equity Warrant performance - newser.com
Published on: 2025-11-09 23:02:45 - newser.com
Can volume confirm reversal in NewAmsterdam Pharma Company N.V. Equity Warrant2025 Risk Factors & Free Low Drawdown Momentum Trade Ideas - newser.com
Can a trend reversal in NewAmsterdam Pharma Company N.V. Equity Warrant lead to recoveryTreasury Yields & Community Consensus Trade Signals - newser.com
Is NewAmsterdam Pharma Company N.V. stock a good choice for value investors2025 Breakouts & Breakdowns & Growth Focused Stock Pick Reports - newser.com
NewAmsterdam Pharma Company N.V. recovery potential after sell offIPO Watch & Weekly High Return Stock Opportunities - newser.com
Is it too late to sell NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Movers & Daily Risk Controlled Trade Plans - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock performs in stagflationQuarterly Performance Summary & Verified Stock Trade Ideas - newser.com
NewAmsterdam Pharma commences $300M offering of ordinary shares - MSN
How Investors May Respond To NewAmsterdam Pharma (NAMS) Sharp Quarterly Revenue Drop and Widening Loss - simplywall.st
Is NewAmsterdam Pharma Company N.V. (KH6) stock attractive post correctionWeekly Risk Summary & Daily Profit Focused Screening - newser.com
Key resistance and support levels for NewAmsterdam Pharma Company N.V.Take Profit & Risk Adjusted Buy/Sell Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. stock poised for growthPortfolio Return Summary & Real-Time Buy Signal Notifications - newser.com
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
NewAmsterdam Pharma (NASDAQ: NAMS) grants 18,000 inducement options at $37 with vesting - Stock Titan
(NAMS) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
January 2028 Options Now Available For NewAmsterdam Pharma (NAMS) - Nasdaq
Using data models to predict NewAmsterdam Pharma Company N.V. Equity Warrant stock movementMarket Growth Review & Risk Controlled Swing Alerts - newser.com
Using economic indicators to assess NewAmsterdam Pharma Company N.V. Equity Warrant potentialJuly 2025 Technicals & Expert Curated Trade Setup Alerts - newser.com
NewAmsterdam Pharma Company NV Stock Analysis and ForecastSell Signals and Alerts & Rapid Wealth Building Tips - earlytimes.in
Pattern recognition hints at NewAmsterdam Pharma Company N.V. upsideJuly 2025 Highlights & Low Risk Investment Opportunities - newser.com
Can NewAmsterdam Pharma Company N.V. Equity Warrant stock withstand economic slowdown2025 Fundamental Recap & Daily Technical Forecast Reports - newser.com
NewAmsterdam Pharma Reports Q3 2025 Financial Results - TipRanks
Can technical indicators confirm NewAmsterdam Pharma Company N.V. Equity Warrant’s reversalJuly 2025 Pullbacks & Low Drawdown Investment Strategies - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock benefit from upcoming earnings reportsPortfolio Risk Summary & Technical Pattern Alert System - newser.com
NewAmsterdam Pharma stock price target raised to $45 from $44 at Leerink - Investing.com
NewAmsterdam Pharma stock price target raised to $44 by RBC Capital - Investing.com Philippines
NewAmsterdam Pharma stock price target raised to $45 from $44 at Leerink By Investing.com - Investing.com Australia
Published on: 2025-11-06 04:01:21 - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock benefit from commodity pricesEarnings Trend Report & Weekly Stock Breakout Alerts - newser.com
Why retail investors pile into NewAmsterdam Pharma Company N.V. Equity Warrant stockJuly 2025 Closing Moves & Weekly High Return Forecasts - newser.com
Will NewAmsterdam Pharma Company N.V. stock outperform international peersJuly 2025 Action & Verified Short-Term Plans - Fundação Cultural do Pará
What does recent volatility data suggest for NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Price Swings & Reliable Price Breakout Signals - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock maintain momentum in 2025Market Trend Report & Free Real-Time Volume Trigger Notifications - newser.com
Real time alert setup for NewAmsterdam Pharma Company N.V. Equity Warrant performance2025 Price Action Summary & Weekly Setup with High ROI Potential - newser.com
How to escape a deep drawdown in NewAmsterdam Pharma Company N.V.Analyst Downgrade & Daily Price Action Insights - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock reacts to oil pricesGap Up & Risk Adjusted Swing Trade Ideas - newser.com
NewAmsterdam Pharma (NAMS): Losses Worsen by 52% Annually as Revenue Forecasts Outpace Market - simplywall.st
Advanced analytics toolkit walkthrough for NewAmsterdam Pharma Company N.V. Equity Warrant2025 Dividend Review & Growth-Oriented Investment Plans - newser.com
Decoding NewAmsterdam Pharma Co NV (NAMS): A Strategic SWOT Insi - GuruFocus
Newamsterdam Pharma Company N V (NAMSW) 財務データ
Newamsterdam Pharma Company N V (NAMSW) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.05%
1.40%
大文字化:
|
ボリューム (24 時間):